Completeness and timeliness: Cancer registries could/should improve their performance

Zanetti, Roberto; Schmidtmann, Irene; Sacchetto, Lidia; Binder-Foucard, F.; Bordoni, Andrea; Coza, Daniela; Ferretti, Stefano; Galcerán, Jaume; Gavin, Anna; Larrañaga, Nerea; Robinson, David; Tryggvadóttír, Laufey; Eycken, E. Van; Zadnik, Vesna; Coebergh, Jan Willem; Rosso, Stefano

doi:10.1016/j.ejca.2013.11.040

Cited by 60 publications

(45 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A recent assessment of the quality of data from cancer registries in Europe concluded that the median latency for completion of incidence ascertainment was 18 months, and additional time required for dissemination was in the order of 3-6 months, with wide variations (Zanetti et al, 2015). Although RORENO has not attained this timeliness, a quantitative evaluation of case ascertainment has yielded high levels of completeness for gastric cancer [a cancer of poor prognosis (De Angelis et al, 2014;Allemani et al, 2015)] and concluded that no meaningful improvements in completeness could be expected after 3 years since diagnosis, which may be considered, in this context, a minimum lag to be respected between diagnosis and the publication of valid incidence estimates (Castro et al, 2012).…”

Section: Discussionmentioning

confidence: 99%

Cancer incidence predictions in the North of Portugal: keeping population-based cancer registration up to date

Castro

Antunes

Lunet

et al. 2016

European Journal of Cancer Prevention

View full text Add to dashboard Cite

Decision making towards cancer prevention and control requires monitoring of trends in cancer incidence and accurate estimation of its burden in different settings. We aimed to estimate the number of incident cases in northern Portugal for 2015 and 2020 (all cancers except nonmelanoma skin and for the 15 most frequent tumours). Cancer cases diagnosed in 1994-2009 were collected by the North Region Cancer Registry of Portugal (RORENO) and corresponding population figures were obtained from Statistics Portugal. JoinPoint regression was used to analyse incidence trends. Population projections until 2020 were derived by RORENO. Predictions were performed using the Poisson regression models proposed by Dyba and Hakulinen. The number of incident cases is expected to increase by 18.7% in 2015 and by 37.6% in 2020, with lower increments among men than among women. For most cancers considered, the number of cases will keep rising up to 2020, although decreasing trends of age-standardized rates are expected for some tumours. Cervix was the only cancer with a decreasing number of incident cases in the entire period. Thyroid and lung cancers were among those with the steepest increases in the number of incident cases expected for 2020, especially among women. In 2020, the top five cancers are expected to account for 82 and 62% of all cases diagnosed in men and women, respectively. This study contributes to a broader understanding of cancer burden in the north of Portugal and provides the basis for keeping population-based incidence estimates up to date.

show abstract

Section: Discussionmentioning

confidence: 99%

Cancer incidence predictions in the North of Portugal: keeping population-based cancer registration up to date

Castro

Antunes

Lunet

et al. 2016

European Journal of Cancer Prevention

View full text Add to dashboard Cite

show abstract

“…It depends on the rapidity with which the registry can collect, process, and report sufficiently complete and accurate data . Timeliness of the registries in this survey (a median of 17 months before complete data are available) is similar to that reported by registries in Europe …”

Section: Discussionmentioning

confidence: 99%

Cancer registries in Africa 2014: A survey of operational features and uses in cancer control planning

Gakunga¹,

Parkin

2015

Intl Journal of Cancer

View full text Add to dashboard Cite

A questionnaire survey of all active population based cancer registries in sub-Saharan Africa obtained information on their characteristics (size, staffing, funding), methods of working, the nature of any links between registries and their respective Health Authorities (national and/or local), and the use of their data in research or cancer control planning. 23/25 registries (92%) responded. Sources of direct funding and estimated amounts from each source were established, and suggest that it is approximately US$8-9 per case registered. Almost half of the funding is used for routine data collection, processing and analysis. Staffing levels vary, partly as a function of the registry size (approximately one FTE per 300 cases registered). Most data collection is active, using multiple sources (median 10 per registry), and is largely paper-based (abstraction onto paper forms), although all use the computer system CanRegV C for data entry, storage and analysis. Most reporting by the registries is remarkably timely, and in general, their results are widely used by health authorities and other stakeholders in planning and evaluating services, while research output is much more variable. These registries are the source of almost all the existing information on cancer incidence and mortality in sub-Saharan Africa, as published in IARC's "Globocan".Cancer is an increasing problem in Africa because of the aging and growth of the population, as well as increased prevalence of risk factors associated with economic transition (including smoking, alcohol, obesity, physical inactivity and reproductive behaviors), and of certain infectious agents of importance in cancer aetiology. Effective planning and evaluation of control measures (prevention, early detection, treatment and care) require reliable and timely data. In low and middle income countries, such data derive principally from the meticulous, step by step cancer registration operations performed by cancer registries.1 In various documents, it has been said that cancer registries cover only 1% of the African population, 2 but this figure refers to those registries appearing in the IARC publication "Cancer Incidence in Five Continents (CI5)". Although it is true that very few African registries have in the past met the high standards of completeness and validity required for comparative studies of cancer incidence (the prime function of "CI5"), there are several functioning registries capable of providing data that can be used for making national estimates of incidence, mortality

show abstract

“…The completeness of incidence, essential in comparative survival studies, was assessed against the literature [26,27]. DCO proportions were high in German registries (over 10%) and Austrian, Bulgarian and Slovakian registries (7-9%).…”

Section: Data Standardisation and Quality Checksmentioning

confidence: 99%

The EUROCARE-5 study on cancer survival in Europe 1999–2007: Database, quality checks and statistical analysis methods

Baili

Hackl

Zielonke³

et al. 2015

European Journal of Cancer

Self Cite

101

View full text Add to dashboard Cite

Completeness and timeliness: Cancer registries could/should improve their performance

Cited by 60 publications

References 30 publications

Cancer incidence predictions in the North of Portugal: keeping population-based cancer registration up to date

Cancer incidence predictions in the North of Portugal: keeping population-based cancer registration up to date

Cancer registries in Africa 2014: A survey of operational features and uses in cancer control planning

The EUROCARE-5 study on cancer survival in Europe 1999–2007: Database, quality checks and statistical analysis methods

Contact Info

Product

Resources

About